Drug-Induced Parkinsonism: Evaluating the Associations

Parkinsonism can be caused not only by idiopathic Parkinson's disease but also by exposure to certain drugs and toxins that interfere with dopaminergic transmission or dopaminergic neurons. The question asks which of the three agents listed — atypical antipsychotics, lithium, and MPTP — are associated with Parkinson's disease/parkinsonism. The correct answer is 1, 2 and 3, i.e., all three are recognized associations.

Analyzing Each Option

• 1. Atypical anti-psychotic drugs: Even "atypical" antipsychotics (e.g., risperidone, olanzapine) retain dopamine D2-receptor blocking activity in the nigrostriatal pathway, albeit generally less than typical antipsychotics. This blockade produces extrapyramidal side effects, including drug-induced parkinsonism (bradykinesia, rigidity, tremor), which is a well-documented and commonly tested association. This statement is correct.
• 2. Lithium: Lithium is a recognized cause of tremor and, at toxic or even therapeutic levels in susceptible individuals, can produce or worsen extrapyramidal symptoms and parkinsonian features (rigidity, bradykinesia), particularly in combination with antipsychotics or in elderly patients. Standard pharmacology and psychiatry references list lithium among drugs that can precipitate parkinsonism. This statement is correct.
• 3. MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine): MPTP is the classic experimental/toxic model of Parkinson's disease. Its metabolite MPP+ is selectively taken up by dopaminergic neurons in the substantia nigra pars compacta and destroys them, producing an irreversible parkinsonian syndrome clinically indistinguishable from idiopathic Parkinson's disease. It is one of the most cited drug/toxin causes of secondary parkinsonism in toxicology and neurology. This statement is correct.

Why the Other Options Are Wrong

• 2 and 3 only: Incorrectly excludes atypical antipsychotics, which are in fact one of the most common iatrogenic causes of drug-induced parkinsonism.
• 1 and 3 only: Incorrectly excludes lithium, which does have a recognized (if comparatively milder) association with parkinsonian/tremor symptoms.
• 1 and 2 only: Incorrectly excludes MPTP, which is in fact the best-established toxic cause of parkinsonism, used precisely because of its strong, direct nigrostriatal dopaminergic toxicity.

Conclusion

Since atypical antipsychotics, lithium, and MPTP are all documented to cause or contribute to parkinsonian features through dopaminergic pathway disruption, the correct combination is 1, 2 and 3.